FHI 360's clinical trials have evaluated the safety, effectiveness and acceptability of virtually every contraceptive method. For example, we are currently supporting the identification and early testing of innovative approaches to a longer-acting injectable contraceptive. The project is the first step toward bringing a game-changing injectable contraceptive to market that will empower couples to determine the size of their families and improve quality of life.